ZACKARY COCO: Open Payments
NPI 1194236935 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 26 payments from 10 companies in 2025. Trend: 2023 $778 · 2024 $510 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $353 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $199 |
| Axsome Therapeutics, Inc. | 5 | $176 |
| ABBVIE INC. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: SPRAVATO, CAPLYTA, Auvelity, REXULTI, VRAYLAR, HETLIOZ, COBENFY, Quviviq.
Industry payments across AR — which companies pay providers there.
